These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3299604)

  • 1. Cisplatin nephrotoxicity.
    Safirstein R; Wiston J
    J UOEH; 1987 Mar; 9 Suppl():216-22. PubMed ID: 3299604
    [No Abstract]   [Full Text] [Related]  

  • 2. Cisplatin nephrotoxicity affects magnesium and calcium metabolism.
    Goren MP
    Med Pediatr Oncol; 2003 Sep; 41(3):186-9. PubMed ID: 12868117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of cisplatin nephrotoxicity by procainamide: does the formation of a cisplatin-procainamide complex play a role?
    Viale M; Vannozzi MO; Pastrone I; Mariggiò MA; Zicca A; Cadoni A; Cafaggi S; Tolino G; Lunardi G; Civalleri D; Lindup WE; Esposito M
    J Pharmacol Exp Ther; 2000 Jun; 293(3):829-36. PubMed ID: 10869382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nephrotoxicity of cisplatin in rats.
    Nakada J; Machida T; Endou H
    Dev Toxicol Environ Sci; 1986; 14():179-82. PubMed ID: 3829973
    [No Abstract]   [Full Text] [Related]  

  • 5. Cyclosporin induces magnesium deficiency in rats and thereby aggravates its own nephrotoxicity: benefit of magnesium supplementation.
    Rob PM; Lebeau A; Schmid H; Sack K; Classen HG
    Transplant Proc; 1994 Jun; 26(3):1736-7. PubMed ID: 8030111
    [No Abstract]   [Full Text] [Related]  

  • 6. Protection against cisplatin-induced nephrotoxicity by Spirulina in rats.
    Mohan IK; Khan M; Shobha JC; Naidu MU; Prayag A; Kuppusamy P; Kutala VK
    Cancer Chemother Pharmacol; 2006 Dec; 58(6):802-8. PubMed ID: 16552571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological blockade of the nephrotoxicity of cisplatin in rats].
    Natochin IuV; Raznik LV; Bakhteeva VT; Ivanov VB; Miazina EM
    Biull Eksp Biol Med; 1986 Oct; 102(10):442-5. PubMed ID: 3768510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amelioration of cisplatin-induced nephrotoxicity by the diuretic acetazolamide in F344 rats.
    Osman NM; Copley MP; Litterst CL
    Cancer Treat Rep; 1984; 68(7-8):999-1004. PubMed ID: 6540145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of cisplatin nephrotoxicity.
    Weiner MW; Jacobs C
    Fed Proc; 1983 Oct; 42(13):2974-8. PubMed ID: 6684595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cis-Diamminedichloroplatinum (II)-DNA adduct formation in renal, gonadal, and tumor tissues of male and female rats.
    Reed E; Litterst CL; Thill CC; Yuspa SH; Poirier MC
    Cancer Res; 1987 Feb; 47(3):718-22. PubMed ID: 3802077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective effects of L-arginine against cisplatin-induced renal oxidative stress and toxicity: role of nitric oxide.
    Saleh S; El-Demerdash E
    Basic Clin Pharmacol Toxicol; 2005 Aug; 97(2):91-7. PubMed ID: 15998355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of organic cation transport inhibitors on cis-diamminedichloroplatinum-induced nephrotoxicity.
    Bird JE; Walser MM; Quebbemann AJ
    J Pharmacol Exp Ther; 1984 Dec; 231(3):752-8. PubMed ID: 6542140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnesium depletion enhances cisplatin-induced nephrotoxicity.
    Lajer H; Kristensen M; Hansen HH; Nielsen S; Frøkiaer J; Ostergaard LF; Christensen S; Daugaard G; Jonassen TE
    Cancer Chemother Pharmacol; 2005 Nov; 56(5):535-42. PubMed ID: 15947931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms for the renal secretion of cisplatin.
    Nelson JA; Santos G; Herbert BH
    Cancer Treat Rep; 1984 Jun; 68(6):849-53. PubMed ID: 6539649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An animal model of cisplatin-induced magnesium deficiency.
    Ormond T; Ryan MP; Pratt IS
    Arch Toxicol Suppl; 1987; 11():270-2. PubMed ID: 3477180
    [No Abstract]   [Full Text] [Related]  

  • 16. Cisplatin nephrotoxicity is mediated by gamma glutamyltranspeptidase, not via a C-S lyase governed biotransformation pathway.
    Wainford RD; Weaver RJ; Stewart KN; Brown P; Hawksworth GM
    Toxicology; 2008 Jul; 249(2-3):184-93. PubMed ID: 18583013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum thymic factor, FTS, attenuates cisplatin nephrotoxicity by suppressing cisplatin-induced ERK activation.
    Kohda Y; Kawai Y; Iwamoto N; Matsunaga Y; Aiga H; Awaya A; Gemba M
    Biochem Pharmacol; 2005 Nov; 70(9):1408-16. PubMed ID: 16154539
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of cisplatin induced nephrotoxicity in mice by ethyl acetate extract of a polypore fungus, Phellinus rimosus.
    Ajith TA; Jose N; Janardhanan KK
    J Exp Clin Cancer Res; 2002 Jun; 21(2):213-7. PubMed ID: 12148580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation of caspase-6 and -7 genes by cisplatin-induced p53 and its functional significance in cisplatin nephrotoxicity.
    Yang C; Kaushal V; Haun RS; Seth R; Shah SV; Kaushal GP
    Cell Death Differ; 2008 Mar; 15(3):530-44. PubMed ID: 18064040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversion by ozone treatment of acute nephrotoxicity induced by cisplatin in rats.
    González R; Borrego A; Zamora Z; Romay C; Hernández F; Menéndez S; Montero T; Rojas E
    Mediators Inflamm; 2004 Dec; 13(5-6):307-12. PubMed ID: 15770045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.